[CAS NO. 1454288-88-0] Rovazolac
PRODUCTS SPECIFICATIONS [1454288-88-0]
DESCRIPTION [1454288-88-0]
Overview
| MDL | - |
|---|---|
| Molecular Weight | 452.45 |
| Molecular Formula | C21H19F3N2O4S |
| SMILES | O=C(OCC)CN1C(C2=CC=C(C3=CC(S(C)(=O)=O)=CC=C3)C=C2)=CC(C(F)(F)F)=N1 |
Summary
Rovazolac is a liver x receptor (LXR) modulator extracted from patent WO2013130892A1.
IC50 & Target
Target: LXR [1]
In Vitro
Rovazolac is an anti-inflammatory drug candidate [1] .
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Appearance
Solid
Shipping
Room temperature in continental US; may vary elsewhere.
Storage
| Powder | -20°C | 3 years |
|---|---|---|
| 4°C | 2 years | |
| In solvent | -80°C | 6 months |
| -20°C | 1 month |
Solvent & Solubility
Ethanol : 25 mg/mL ( 55.25 mM ; Need ultrasonic)
Stock Solutions
| Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
|---|
| 1 mM | 2.2102 mL | 11.0509 mL | 22.1019 mL |
| 5 mM | 0.4420 mL | 2.2102 mL | 4.4204 mL |
| 10 mM | 0.2210 mL | 1.1051 mL | 2.2102 mL |
-
1.
-
2.
Add each solvent one by one: 10% EtOH >> 90% corn oil
Solubility: ≥ 2.5 mg/mL (5.53 mM); Clear solution
Synonyms